Tag Archives: PharmaFutures

For What it’s Worth: Study Probes Evolving Value Schemes

PharmaFutures’ Pathways to Value: Pharma in a Changing World explains how the industry may move forward to combine business imperatives and social mandates through new strategies for determining value and reimbursement for medicines. The study determines that collaboration across three fronts is needed to ensure that value is recognized and adapted over time, taking into […]
Posted in Emerging Markets, Europe, Market Access, pricing, R&D, Regulatory, Strategy | Also tagged , , , , , , | Leave a comment
  • Categories

  • Meta